Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

3rd EurocanPlatform Translational Research Course /
Post-translational modification (PTM) profiling – a novel tool for mapping the PTM landscape in cancer

12th - 16th Oct 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.01.16
Views: 2286

Dr Yifat Merbl – Weizmann Institute of Science, Rehovot, Israel

Dr Merbl discusses her lab’s research at the 3rd EurocanPlatform Translational Research Course in profiling changes in post-translational modifications (PTM) which allows the precise characterisation of different cancer sub-types, looking at lung adenocarcinoma as an example. Previous work has focused on genomic and transcriptional changes whilst proteomics and the protein modification landscape has remained untouched.

She explores the significance this will have on clinical practise, what the next steps are, what obstacles exist to this work and what the eventual benefits will be.

Learn more about Dr Merbl’s work and the Merbl lab here

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation